Correction: Overcoming resistance to αPD-1 of MMR-deficient tumors with high tumor-induced neutrophils levels by combination of αCTLA-4 and αPD-1 blockers

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413170/
https://www.ncbi.nlm.nih.gov/pubmed/36002190
http://dx.doi.org/10.1136/jitc-2022-005059corr1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413170/
https://www.ncbi.nlm.nih.gov/pubmed/36002190
http://dx.doi.org/10.1136/jitc-2022-005059corr1

Ejemplares similares